TOKYO -- Takeda Pharmaceutical last week set the terms for the issuance of three tranches of straight bonds totaling 184 billion yen ($1.27 billion). But the Japanese drugmaker fell short of its 200 billion yen target, a sign that the market is now wary about large issuances.
Bonds
Takeda's downsized bond offering reveals new investor caution
Japan drugmaker missed goal in recent issuance, despite high-quality debt
Takeda Pharmaceutical sought to raise 200 billion yen in its recent three-tranche issuance. (Photo by Kohei Yamada)
Read Next
Latest on Bonds
